Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China SXT Pharmaceuticals ( (SXTC) ) has shared an announcement.
China SXT Pharmaceuticals, Inc. has announced a special meeting of shareholders scheduled for July 28, 2025, to vote on significant amendments to its memorandum and articles of association. The proposed changes include the creation of a dual class share structure, introducing Class B shares with enhanced voting rights, and re-designating existing shares into Class A and Class B categories. This move is aimed at strengthening the company’s governance structure and could have implications for shareholder voting power and company control dynamics.
More about China SXT Pharmaceuticals
China SXT Pharmaceuticals, Inc. is a company incorporated in the British Virgin Islands, operating in the pharmaceutical industry. It is listed on NASDAQ under the ticker SXTC.
Average Trading Volume: 4,591,262
Technical Sentiment Signal: Sell
Current Market Cap: $203M
For a thorough assessment of SXTC stock, go to TipRanks’ Stock Analysis page.